We are live on ! Find out more
JAFL

Jay A. Fishman Ltd Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$530M
AUM Growth
+$40M
Cap. Flow
+$1.43M
Cap. Flow %
0.27%
Top 10 Hldgs %
57%
Holding
96
New
3
Increased
30
Reduced
33
Closed
6

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$6.9M
2
LEN icon
Lennar Class A
LEN
+$6.32M
3
HD icon
Home Depot
HD
+$2.34M
4
GM icon
General Motors
GM
+$2.29M
5
AMZN icon
Amazon
AMZN
+$1.69M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.1M
2
CELG
Celgene Corp
CELG
+$3.6M
3
SBUX icon
Starbucks
SBUX
+$2.75M
4
MDT icon
Medtronic
MDT
+$826K
5
CVS icon
CVS Health
CVS
+$767K

Sector Composition

Rank Sector Weight
1 Industrials 19.39%
2 Technology 17.57%
3 Healthcare 15.13%
4 Financials 14.11%
5 Consumer Discretionary 12.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VB icon
26
Vanguard Small-Cap ETF
VB
$79.9B
$4.74M 0.89%
32,037
+690
+2% +$99.8K
AGN
27
DELISTED
Allergan plc
AGN
$4.35M 0.82%
26,574
-56,123
-68% -$10.1M
DEO icon
28
Diageo
DEO
$47.3B
$4.21M 0.79%
28,836
-335
-1% -$46.2K
BAC icon
29
Bank of America
BAC
$436B
$4M 0.75%
135,521
+23,150
+21% +$638K
MO icon
30
Altria Group
MO
$122B
$3.93M 0.74%
55,082
+5,475
+11% +$367K
SHW icon
31
Sherwin-Williams
SHW
$80.7B
$3.4M 0.64%
24,900
MRK icon
32
Merck
MRK
$323B
$3.25M 0.61%
60,619
-10,386
-15% -$576K
GM icon
33
General Motors
GM
$78.7B
$2.62M 0.49%
63,800
+52,740
+477% +$2.29M
MON
34
DELISTED
Monsanto Co
MON
$2.5M 0.47%
21,389
-115
-0.5% -$13.7K
COST icon
35
Costco
COST
$422B
$2.46M 0.46%
13,205
-1,817
-12% -$314K
COP icon
36
ConocoPhillips
COP
$141B
$2.42M 0.46%
44,125
-1,600
-3% -$82.3K
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.26M 0.43%
11,406
DHR icon
38
Danaher
DHR
$138B
$2.21M 0.42%
26,894
+1,579
+6% +$128K
TXT icon
39
Textron
TXT
$16.7B
$2.17M 0.41%
38,277
-2,800
-7% -$152K
GD icon
40
General Dynamics
GD
$105B
$2.08M 0.39%
10,200
NBL
41
DELISTED
Noble Energy, Inc.
NBL
$2.03M 0.38%
69,636
-11,136
-14% -$305K
PG icon
42
Procter & Gamble
PG
$346B
$1.79M 0.34%
19,507
-3,596
-16% -$323K
NEE icon
43
NextEra Energy
NEE
$185B
$1.66M 0.31%
42,520
+1,252
+3% +$48.3K
CSCO icon
44
Cisco
CSCO
$452B
$1.62M 0.31%
42,405
-1,025
-2% -$36.6K
EFA icon
45
iShares MSCI EAFE ETF
EFA
$76.8B
$1.45M 0.27%
20,600
-300
-1% -$20.9K
EXP icon
46
Eagle Materials
EXP
$6.69B
$1.36M 0.26%
11,960
+8,545
+250% +$925K
IJH icon
47
iShares Core S&P Mid-Cap ETF
IJH
$123B
$1.3M 0.24%
34,200
+50
+0.1% +$1.85K
PJT icon
48
PJT Partners
PJT
$4.36B
$1.23M 0.23%
26,907
-167
-0.6% -$6.79K
CBOE icon
49
Cboe Global Markets
CBOE
$30.2B
$1.22M 0.23%
9,808
-300
-3% -$35.1K
DE icon
50
Deere & Co
DE
$169B
$1.2M 0.23%
7,670
-50
-0.6% -$7K

Similar funds

Jay A. Fishman Ltd's Q4 2017 Portfolio in Review

As of Q4 2017, Jay A. Fishman Ltd held 96 positions worth $530M, up 8.1% from $490M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Jay A. Fishman Ltd's Q4 2017 filing shows 3 new, 30 increased, 33 reduced and 6 closed positions. Its largest new stake was Ford: 42,861 shares worth $535K. The largest sale was Allergan plc, an estimated $10.1M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Jay A. Fishman Ltd's largest Q4 2017 buy was Ford: 42,861 shares worth $535K.
  • Jay A. Fishman Ltd added most to Intel in Q4 2017, an estimated $6.9M increase.
  • Jay A. Fishman Ltd's biggest Q4 2017 reduction was Allergan plc, cutting an estimated $10.1M.
  • Jay A. Fishman Ltd fully exited Celgene Corp in Q4 2017, selling an estimated $3.6M.
  • Jay A. Fishman Ltd's ten largest holdings make up 57% of its $530M portfolio in Q4 2017.
  • Jay A. Fishman Ltd opened 3 new positions and closed 6 in Q4 2017.
  • Jay A. Fishman Ltd's portfolio value rose 8.1% quarter-over-quarter to $530M.

Based on Jay A. Fishman Ltd's 13F filing for Q4 2017, filed 5 Feb 2018.